As consumers, payers, and regulatory agencies require evidence regarding health care quality, the demand for process of care measures will grow. Although outcome measures of quality represent the desired end results of health care, validated process of care measures provide an important additional element to quality improvement efforts, as they illuminate exactly which provider actions could be changed to improve patient outcomes. In this essay, we discuss the advantages and disadvantages of process measures of quality, and outline some practical strategies and issues in implementing them.
Quality of health care has become a national and international six aims of being effective, safe, patient-centered, timely, efficient, and equitable [4] . Whereas the aims of effectiveness policy issue. Decades of study indicate that quality of care needs improvement all over the world, and therefore sen-and safety of health care are nearly universal, societies and cultures around the world differ more in how much they timent has grown that public disclosure of information about quality of care should be one component of clinical gov-emphasize the additional aims of patient-centeredness, timeliness, efficiency, and equity. Process of care measures of ernance [1] . The United States government has developed the Agency for Healthcare Research and Quality (AHRQ) quality assess the degree to which providers perform health care processes demonstrated to achieve the desired aims and and the National Quality Forum to promote the development and reporting of quality measures [2] . the degree to which they avoid processes that avert the desired aims. Readers of this journal are well aware that more than thirty years ago, Donabedian proposed that we can measure the Public agents and payers' ultimate concern rests with providers' impact on patient outcomes, and most of their quality of health care by observing its structure, its processes, and its outcomes [3] . The Institute of Medicine (IOM) in the measures of quality to date have focused on this. For example, the Center for Medicare and Medicaid Services (CMS formerly US has defined health care quality as 'the degree to which health services for individuals and populations increase the the Health Care Financing Administration, HCFA), which administers the Medicare entitlement program for the elderly likelihood of desired health outcomes and are consistent with current professional knowledge' [4] . The IOM's definition in the US, began by releasing mortality rates for hospitals [8] . The need for risk adjustment when comparing different and framework thus incorporate two of Donabedian's three elements in a broad approach to measuring health care quality: providers became evident, and subsequent efforts attempted this. For example, several US state governments including (1) determining effects of health care on desired outcomes, including a relative improvement in health, and in consumer New York, Pennsylvania, and California provided their citizens with publicly available report cards containing riskevaluations or experience of health care and (2) assessing the degree to which health care adheres to processes that are adjusted mortality rates for cardiac surgery by hospital and surgeon [9] [10] [11] [12] . proven by scientific evidence, professional consensus to affect health, or that concur with patient preference [5] [6] [7] . The
Measures of the process of care that affect outcomes were initially considered too technical for public or regulatory use. IOM has further suggested that health care should have the Theoretically, providers would respond to publicly reported discuss practical strategies for using quality measures for improvement. outcome measurement by developing and implementing their own internal report cards focused on evidence-based process measures. However, given the complexity and expense of developing clinical guidelines and process measures and keep-Advantages and disadvantages of process ing them updated, and the infancy of clinical information measures of quality of care systems that would track the clinical process routinely, individual provider organizations have had difficulty in-There is considerable debate regarding whether quality meascorporating process measurement into their operations. In ures should evaluate processes or outcomes of care. Before the last five years, joint efforts by providers, professional proceeding to develop process indicators, those considering societies, monitoring agencies, and quality-of-care experts this may find it useful to understand their strengths and have begun to assist in identifying and implementing ap-limitations. Within the categories of process and outcome, propriate process-of-care measures. In addition, government there are good and bad measures, but some specific adand payers have a better understanding of the difficulty of vantages and disadvantages apply broadly to all process risk-adjustment for outcome measures such as mortality rates, measures compared with outcomes (Table 1) . and their own interest in process of care measures of quality On the plus side, process measures can be used to provide has grown. The National Committee on Quality Assurance feedback for quality improvement initiatives. Because many (NCQA) in the United States collects data on HEDIS  quality factors can influence patient outcomes, process measures measures and includes evidence-based measures of health have the potential to identify for clinicians exactly which plan processes of care [13] . In the US, these measures are processes they followed or didn't follow that had the potential part of NCQA's health plan accreditation program and are to affect patient outcomes. Process measures provide inused by some employers, insurers, and government payers formation that is actionable; i.e. what is being done well to choose participating health plans. CMS (formerly HCFA) and what needs improvement. When process measures are in the US has also proceeded from reporting on Medicare developed well, so that they accurately reflect the care that beneficiary mortality rates to developing, measuring, and clinicians are delivering, clinicians feel accountable for them. reporting on evidence-based hospital and outpatient care In contrast, many other factors affect health care outcomes processes [14] . Although HCFA has released data on indicator that are beyond the provider's control. When a clinician performance to the public only by state and not by provider, discovers that his patient had worse outcomes than another several US states have passed or are considering legislation clinician's patients, it is unclear what he or she should be to collect and publish the same indicators for hospitals doing about it. When data collection about process of care and practices in those states (B. Miller, Maryland Hospital is generated unobtrusively simply by an electronic patient Association, personal communication).
record when a provider performs the process, these measures In the US, where employer-provided health insurance is become even more attractive and feasible because they elimthe norm, consortia of employers are also using quality inate burdensome additional data collection. measures to assess and select providers, and these are also Secondly, most process measures require less risk adbeginning to incorporate some evidence-based measures of justment for patient illness than do most outcome measures. structure and process. Whereas the first effort of this type, The use of a process measure requires defining a population the Cleveland Health Quality Choice program [15] , focused that is eligible to receive the process such as which patients on outcome measures, newer efforts are now including with asthma should receive anti-inflammatory medications or evidence-based, validated structure and process measures. For which patients should receive beta-blockers or aspirin after example, The Leapfrog group [16], a health care purchasing myocardial infarction. Once the eligible population is speconsortium representing Fortune 500 companies, has de-cified, further risk adjustment is generally not required, alveloped a national measure of quality of intensive care unit though it can be useful. In contrast, comparing mortality rates (ICU) care and provides incentives for their employees to or other outcomes for specific clinical conditions requires risk purchase health care from hospitals that meet this standard. adjustment. Risk adjustment requires definition and measureIn the area of validated structural and process measures, ment of many patient characteristics, including physiological, the standard includes whether intensive care specialists are anatomical, and health status data that are not part of routine monitoring the ICU, which has been demonstrated to improve administrative databases at present, that may not be part of patient outcomes [17] .
medical records, and that may be expensive to collect. In Health care quality measures, including process measures, addition, existing risk adjustment models often perform are developed for varied audiences who may wish to use poorly when applied to new data sets, limiting application of them for health care purchasing, utilization, or performance a common risk adjustment model to all providers [19, 20] . improvement. For all these purposes it is imperative that The development of new risk adjustment models is analytically they are meaningful, scientifically sound, generalizable, and complex, requiring expert statistical analytical resources and interpretable [18] . To achieve this, quality measures must be a large sample of patients available for the development designed and implemented with scientific rigor. In this essay, process. Using process measures applied to an accurately we present an overview of the advantages and disadvantages defined population avoids some of the time and expense that risk adjustment entails. of using process measures as quality of care measures, and example, while many clinicians will document laboratory the time for measurement. In contrast, care delivery occurs testing or use of medications, it is rare to document conin a shorter period of time, and every eligible patient receives versations in which patients are educated about care of their the specific process of care being evaluated.
illness. Thus, use of certain processes as indicators of care On the other hand, there are several disadvantages to may be dictated by availability of data, rather than the relative process measures. Firstly, to be valid, there must be a strong importance of the element of care. In addition, a provider relationship between the process and outcome measures.
may adhere well to one part of the process but not to another. These links between process and outcomes can come from Therefore, if process measures are not comprehensive and previously published evidence, or may be demonstrated for do not cover all the important parts of the process that can the group whose quality of care is being evaluated. The prior affect outcomes, they may be misleading to users. evidence supporting the relationship may be weak or nonexistent for many processes even when they are truly linked to outcomes. Even when studies have been carried out, they may not demonstrate true process-outcome linkages. For Practical strategies for developing quality example, observational studies may show paradoxical as-measures sociations of good care with inferior outcomes because of confounding by indication. In confounding by indication, As we have discussed previously, the audience for and use sicker patients (who subsequently have worse outcomes) of the quality measure will influence how the measure is receive more or better care, setting up the paradoxical obdeveloped and how the results are presented. Quality measures servation that good care is linked to inferior outcomes. This are in general used by provider or care management orphenomenon is particularly problematic for patients with ganizations to evaluate and enhance performance through chronic illnesses such as asthma, for which measures of quality improvement initiatives, by purchasers and patients intrinsic disease severity are poor. Therefore, it may be to inform health care decision making, or by accreditors and difficult to find evidence to support valid process measures. regulators to monitor organizations.
Secondly, when evidence linking process and outcomes is absent yet providers believe the process is important, or
Internal quality improvement initiatives even if such evidence is available, providers may desire to demonstrate the relationship between a process and outcome For internal organizational quality improvement initiatives, measure in their organization. This need may be especially more detailed, less aggregated measures of quality may be strong when a clinical unit or quality improvement effort is more helpful than summary measures. Providers want inrequesting additional resources from their administrators to formation regarding how to improve specific processes. As support an evaluation effort or a change in process. If the such, the unit of analysis for these initiatives tends to be professional and scientific community has not conducted the small, such as the individual unit, practice, or clinician. These needed studies, or these studies are thought to be inapplicable types of measure often require significant technical detail. An to a specific organization's population, then demonstrating important consideration in these types of measure is that the link between process and outcome is prohibitively ex-clinicians believe that the process is related to the outcome pensive and often impossible to achieve for any one or-such that improvement in the process will result in imganization. provement in outcomes. Without this belief, it is often Thirdly, while providers may care about process measures, necessary to establish the link between process and outcome. patients and non-clinicians generally place little value on Data collection for quality improvement can be made part them; they care about outcomes and believe it is the provider's of routine care by existing staff and thus marginal costs responsibility to perform the appropriate processes and to are minimal. Electronic medical record systems play a very avoid harmful ones. Therefore, the measures mean little to important role here, and whenever possible, quality assessconsumers or purchasers for plan or provider selection, and ment efforts should attempt to obtain needed data by remay be less useful to a provider organization in its marketing placing usual clinical data collection with collection of efforts.
standardized data elements. Finally, when used internally for Fourthly, most feasible process measures are usually in-quality improvement, the statistical significance of the results dicators for a very specific element of the care process rather is often less important than the practical interpretation or than comprehensive measures of how care is delivered. For the visual impact of differences in a graphic presentation. example, national asthma guidelines recommend a com-For example, data from these initiatives are often presented prehensive approach to care, including appropriate medication as run charts, indicating a rate or score trend over time, with clinically important changes illustrated as crossing lines use, periodic assessment of disease status, patient education representing acceptable upper or lower bounds rather than to develop and maintain process measures have made them more feasible. To be valid, process measures should have statistically significant differences.
links to important outcomes, or should at least be determined by consensus methods to be judged by clinical experts to be Purchasers and patients important to patient outcomes. The past decade has brought If the audience for the measures is purchasers or patients and a greater emphasis on synthesizing the evidence basis for the intent to provide information for health care purchasing how process of care affects outcomes and has made this decisions, summary or aggregated data are more helpful. information more readily available to the provider community These groups may prefer a comprehensive measure that is as well as the public. In the future this will provide the presented in a way that is understandable to patients, benefit ultimate base for the development of process measures of managers, and enrollees. For these groups, it is important quality. that the process measure is already demonstrated to have a Finally, practical strategies were reviewed for various uses strong link to outcome, as they do not perceive it as their of process of care measures for internal quality improvement, role to conduct clinical studies establishing these links. It is for choice of providers by patients or purchasers, and for more important for these audiences that patients and enrollees accreditation and regulatory purposes. rather than providers believe the measure evaluates an important domain of quality. Statistical significance among groups becomes increasingly important; patients and enrollees
